BSE Live
Dec 26, 16:01Prev. Close
5563.80
Open Price
5563.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:56Prev. Close
5566.00
Open Price
5539.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5535.00 (39)
| Key Financial Ratios of Alkem Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 199.11 | 130.30 | 121.33 | |
| Diluted EPS (Rs.) | 199.11 | 130.30 | 121.33 | |
| Cash EPS (Rs.) | 216.73 | 147.73 | 138.06 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 1,008.09 | 823.61 | 707.93 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 1,008.09 | 823.61 | 707.93 | |
| Dividend / Share(Rs.) | 12.50 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 1,124.00 | 971.26 | 816.24 | |
| PBDIT/Share (Rs.) | 239.65 | 171.73 | 145.14 | |
| PBIT/Share (Rs.) | 222.03 | 154.30 | 128.41 | |
| PBT/Share (Rs.) | 204.97 | 141.97 | 115.85 | |
| Net Profit/Share (Rs.) | 199.11 | 130.30 | 121.33 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 21.32 | 17.68 | 17.78 | |
| PBIT Margin (%) | 19.75 | 15.88 | 15.73 | |
| PBT Margin (%) | 18.23 | 14.61 | 14.19 | |
| Net Profit Margin (%) | 17.71 | 13.41 | 14.86 | |
| Return on Networth / Equity (%) | 19.75 | 15.82 | 17.13 | |
| Return on Capital Employed (%) | 18.24 | 10.97 | 12.50 | |
| Return on Assets (%) | 15.26 | 9.76 | 11.35 | |
| Total Debt/Equity (X) | 0.06 | 0.41 | 0.34 | |
| Asset Turnover Ratio (%) | 86.18 | 72.79 | 76.41 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 4.48 | 6.69 | 5.97 | |
| Quick Ratio (X) | 3.79 | 5.57 | 4.21 | |
| Inventory Turnover Ratio (X) | 7.65 | 5.93 | 4.74 | |
| Dividend Payout Ratio (NP) (%) | 6.27 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 5.76 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 93.73 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 94.24 | 0.00 | 0.00 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 93.72 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key